Vitreous tamponades are essentials used in vitrectomy procedures conducted in the human eye that either assist in healing/reattachment of the retina or provide a replacement to a clouded vitreous humor. This report studies the current as well as future prospects of the global vitreous tamponades market. The report comprises an elaborate executive summary that includes extensive analysis of the vitreous tamponade products and their market based on applicability, effectiveness, sales revenue and geographic presence. In addition, the executive summary includes a market snapshot, which comprises market trends and dynamics of various market segments that are included in this report. The executive summary chapter also includes a waterfall diagram that reflects the market size of various segments for the year 2013.
This 73 page report gives readers a comprehensive overview of the vitreous tamponades market. Browse through 9 data tables and 15 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/vitreous-tamponades-market.html
The market overview section of the report comprises analysis of the vitreous tamponades market by considering factors that determine the market dynamics such as drivers, restraints and opportunities. This section of the report also includes Porter’s five forces analysis that covers the global market in terms of bargaining power of buyers and suppliers, threat of new entrants and substitutes, and competitive rivalry. In addition, the section comprises market attractiveness analysis that helps gain knowledge about the most attractive and leading geographic region in the global vitreous tamponades market. The market overview section also includes market share analysis of the key players (in terms of value %) operating in the vitreous tamponades market for the year 2013, and value chain analysis that studies major steps involved in the preparation and distribution of vitreous tamponades by manufacturers.
Based on types, the vitreous tamponades market has been segmented into gaseous tamponades and liquid tamponades. The liquid tamponades segment has been further sub-segmented into silicone oil and perfluorocarbon liquids. The gaseous tamponades segment on the other hand includes market revenue of SF6 and C3F8 collectively. The market for these two types of vitreous tamponades has been extensively analyzed based on factors such as sales revenues, usage pattern, developments and geographic presence. The market size and forecast in terms of revenue (USD million) for each of these types have been provided for the period from 2012 to 2020, considering 2013 as the base year. The report also provides the compound annual growth rate (CAGR) for each segment for the forecast period from 2014 to 2020.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving vitreous tamponades market during 2014 – 2020: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4233
Geographically, the vitreous tamponades market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Each geographical region has been further segmented, based on types of tamponades, into gaseous tamponades and liquid tamponades. The market size and forecast for each of these regions have been provided for the period from 2012 to 2020, along with CAGR (%) for the forecast period from 2014 to 2020. The research study also incorporates the competitive scenario in these regions.
The report also provides a heat map analysis of the major players in the vitreous tamponades market have been included. A list of recommendations has been provided for new entrants as well as existing players to help establish a strong presence in the market and increase market shares. The report concludes with profiles of major players in the vitreous tamponades market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Alcon, Inc., Valeant Pharmaceuticals International, Inc. (parent of Bausch + Lomb), Carl Zeiss Meditec AG, Dutch Ophthalmic Research Center B.V., Fluoron GmbH, Croma – Pharma AG, and AL.CHI.MI.A Srl.